Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Apogee Therapeutics Inc shares valued at $990,775 were purchased by McKenna Mark C. on Dec 12 ’24. At $49.54 per share, McKenna Mark C. acquired 20,000 shares. The insider’s holdings grew to 20,000 shares worth approximately $0.89 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Dambkowski Carl sold 4,540 shares, netting a total of over 221,363 in proceeds. Following the sale of shares at $48.76 each, the insider now holds 258,073 shares.
Before that, CARL DAMBKOWSKI had added 18,160 shares to its account. In a trade valued at $878,581, the Officer bought Apogee Therapeutics Inc shares for $48.38 each.
As published in their initiating research note from Canaccord Genuity on November 25, 2024, Apogee Therapeutics Inc [APGE] has been a Buy and the price target has been revised to $89. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of December 20, 2023, BTIG Research has initiated its “Buy” rating for APGE. Earlier on August 08, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for APGE stock.
Analyzing APGE Stock Performance
During the last five days, there has been a drop of approximately -8.37%. Over the course of the year, Apogee Therapeutics Inc shares have jumped approximately 59.95%. Shares of the company reached a 52-week high of $72.29 on 03/13/24 and a 52-week low of $27.05 on 01/08/24. A 50-day SMA is recorded $51.11, while a 200-day SMA reached $50.77. Nevertheless, trading volume fell to 0.51 million shares from 0.36 million shares the previous day.
Support And Resistance Levels for Apogee Therapeutics Inc (APGE)
According to the 24-hour chart, there is a support level at 42.64, which, if violated, would cause prices to drop to 40.58. In the upper region, resistance lies at 47.80. The next price resistance is at 50.90. RSI (Relative Strength Index) is 42.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.60, which suggests the price will decrease in the coming days. Percent R is at 75.86%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
